Circulating Endothelial Cells and Platelet Microparticles in Mitral Valve Disease With and Without Atrial Fibrillation
- 12 August 2014
- journal article
- Published by SAGE Publications in Angiology
- Vol. 66 (7) , 631-637
Abstract
Hypercoagulability in mitral valve disease (MVD), a cause of atrial fibrillation (AF) and stroke, is potentially due to endothelial damage/dysfunction (marked by circulating endothelial cells [CECs]), platelet activation (soluble P-selectin [sPsel], platelet microparticles [PMPs], and soluble CD40 [sCD40]), and oxidized low-density lipoprotein (oxLDL) cholesterol. We measured these variables in 24 patients with MVD as well as in 21 with MVD + AF and compared them with 20 healthy controls (HCs). The CECs and PMPs were measured by flow cytometry; sPsel, oxLDL, and CD40 by enzyme-linked immunosorbent assay. Compared with HCs, sPsel and PMPs were equally higher in MVD and MVD + AF; sCD40 and oxLDL were higher in MVD + AF than in HCs and MVD; and CECs were higher in MVD than in the HCs, with further increases in MVD + AF (all P < .001). We conclude that excess platelet activation is present in MVD regardless of AF, and that increased endothelial damage in MVD is greater when compounded by AF.Keywords
This publication has 40 references indexed in Scilit:
- Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and RhythmJACC, 2013
- Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agentsEP Europace, 2012
- Microparticles and Arterial DiseaseSeminars in Thrombosis and Hemostasis, 2009
- Soluble CD40 Ligand, Platelet Surface CD40 Ligand, and Total Platelet CD40 Ligand in Atrial FibrillationChest, 2008
- Levels of Circulating Procoagulant Microparticles in Nonvalvular Atrial FibrillationThe American Journal of Cardiology, 2007
- Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: Studies using a new digital flow cytometerCytometry Part A, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular diseaseThrombosis and Haemostasis, 2005
- Circulating endothelial cellsThrombosis and Haemostasis, 2005
- The role of CD40 in CD40L- and antibody-mediated platelet activationThrombosis and Haemostasis, 2005